JANE STREET GROUP, LLC - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 52 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q2 2020$19,000
+90.0%
28,881
+64.7%
0.00%–
Q1 2020$10,000
-65.5%
17,533
-11.4%
0.00%–
Q4 2018$29,000
-90.1%
19,799
-44.6%
0.00%
-100.0%
Q3 2017$293,000–35,731–0.00%–
 Download
Other shareholders

There were no reported owners of NABRIVA THERAPEUTICS PLC in Q3 2020.

NameSharesValueWeighting ↓
View complete list of NABRIVA THERAPEUTICS PLC shareholders